Document Details

Filing Date
Jan 26, 2024
Document Date
Jan 26, 2024
Form Description
SEC Staff Letter: 14A-8
Company
ArriVent Biopharma
Issuer
ARRIVENT BIOPHARMA, INC.

Filing Formats